US 7964646
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
granted A61PA61P1/02A61P1/04
Quick answer
US patent 7964646 (3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 47
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18